Scott Kellen
Financieel Directeur/CFO bij DIAMEDICA THERAPEUTICS INC.
Vermogen: 138 087 $ op 30-04-2024
Actieve functies van Scott Kellen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
DIAMEDICA THERAPEUTICS INC. | Financieel Directeur/CFO | 01-04-2018 | - |
Investor Relations Contact | 01-04-2018 | - | |
Bedrijfssecretaris | 01-04-2018 | - |
Loopbaan van Scott Kellen
Eerdere bekende functies van Scott Kellen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PANBELA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01-10-2015 | 01-04-2018 |
Financieel Directeur/CFO | 01-10-2015 | 01-04-2018 | |
Bedrijfssecretaris | 01-10-2015 | 01-04-2018 | |
Transoma Medical, Inc.
Transoma Medical, Inc. Medical/Nursing ServicesHealth Services Transoma Medical, Inc., headquartered in St. Paul, Minnesota, is a medical technology company engaged in developing, manufacturing and distributing implantable, wireless diagnostic and monitoring systems. Transoma is focused specifically on diagnostic and monitoring technology and dedicated to providing physicians with information needed to accurately and quickly diagnose unexplained, infrequent symptoms and to monitor changing, often asymptomatic complex arrhythmias. Transoma has an extensive technology platform based on more than 20 years experience in developing implantable wireless diagnostic systems for use in biomedical research. These innovative tools have played a key role in drug discovery, pre-clinical evaluation of safety and efficacy, and other academic and government basic research. Customers have turned to DSI for more accurate, timely physiological data, highly humane research practices, and faster times to market. In 2003 the Patient Management division was formed utilizing this proven technology platform and paving the way for the formation of Transoma Medical. | Financieel Directeur/CFO | 01-11-2007 | 01-05-2009 |
ev3, Inc.
ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | Comptroller/Controller/Auditor | 01-01-2005 | 01-10-2007 |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 01-03-2003 | 01-04-2005 |
Sun Biopharma, Inc. /Old/ | Financieel Directeur/CFO | - | - |
KIPS BAY MEDICAL, INC. | Directeur/Bestuurslid | 22-09-2015 | - |
Operationeel Directeur | 08-02-2010 | - | |
Financieel Directeur/CFO | 14-04-2010 | - | |
Investor Relations Contact | 11-04-2011 | - | |
Bedrijfssecretaris | 14-04-2010 | - |
Opleiding van Scott Kellen
University of South Dakota | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 9 |
Operationeel
Director of Finance/CFO | 5 |
Corporate Secretary | 3 |
Comptroller/Controller/Auditor | 3 |
Sectoraal
Health Technology | 6 |
Commercial Services | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
DIAMEDICA THERAPEUTICS INC. | Health Technology |
PANBELA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
ev3, Inc.
ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | Health Technology |
Kips Bay Medical, Inc.
Kips Bay Medical, Inc. Medical SpecialtiesHealth Technology Kips Bay Medical, Inc. was a medical device company focused on developing, manufacturing and commercializing its proprietary external saphenous vein support technology for use in coronary artery bypass grafting surgery. Its product, eSVS MESH, was a nitinol mesh sleeve that was placed over the saphenous vein graft during CABG surgery and is designed to constrict the vein and prevent expansion of the vein graft and resulting injury due to increased pressure. The company was founded by Manuel A. Villafaña on May 1, 2007 and was headquartered in Minneapolis, MN. | Health Technology |
Sun Biopharma, Inc. /Old/ | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
Transoma Medical, Inc.
Transoma Medical, Inc. Medical/Nursing ServicesHealth Services Transoma Medical, Inc., headquartered in St. Paul, Minnesota, is a medical technology company engaged in developing, manufacturing and distributing implantable, wireless diagnostic and monitoring systems. Transoma is focused specifically on diagnostic and monitoring technology and dedicated to providing physicians with information needed to accurately and quickly diagnose unexplained, infrequent symptoms and to monitor changing, often asymptomatic complex arrhythmias. Transoma has an extensive technology platform based on more than 20 years experience in developing implantable wireless diagnostic systems for use in biomedical research. These innovative tools have played a key role in drug discovery, pre-clinical evaluation of safety and efficacy, and other academic and government basic research. Customers have turned to DSI for more accurate, timely physiological data, highly humane research practices, and faster times to market. In 2003 the Patient Management division was formed utilizing this proven technology platform and paving the way for the formation of Transoma Medical. | Health Services |
- Beurs
- Insiders
- Scott Kellen
- Ervaring